Detalles de la búsqueda
1.
Early platelet variation during concomitant chemo-radiotherapy predicts adjuvant temozolomide-induced thrombocytopenia in newly diagnosed glioblastoma patients.
Support Care Cancer
; 27(2): 477-484, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29978325
2.
Temozolomide Plus Bevacizumab in Elderly Patients with Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial (ATAG).
Oncologist
; 23(5): 524-e44, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29472310
3.
Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes.
Breast Cancer Res
; 19(1): 98, 2017 Aug 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-28830573
4.
Short report: Monitoring ESR1 mutations by circulating tumor DNA in aromatase inhibitor resistant metastatic breast cancer.
Int J Cancer
; 137(10): 2513-9, 2015 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25994408
5.
Prognostic value of circulating short-length DNA fragments in unresected glioblastoma patients.
Transl Oncol
; 42: 101897, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38340682
6.
Cell-free DNA and circulating TERT promoter mutation for disease monitoring in newly-diagnosed glioblastoma.
Acta Neuropathol Commun
; 8(1): 179, 2020 11 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33148330
7.
Deleterious impact of a generic temozolomide formulation compared with brand-name product on the kinetic of platelet concentration and survival in newly diagnosed glioblastoma.
Fundam Clin Pharmacol
; 34(4): 484-494, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31994757
8.
Simultaneous detection of EGFR amplification and EGFRvIII variant using digital PCR-based method in glioblastoma.
Acta Neuropathol Commun
; 8(1): 52, 2020 04 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-32303258
9.
Randomised phase II trial evaluating the safety of peripherally inserted catheters versus implanted port catheters during adjuvant chemotherapy in patients with early breast cancer.
Eur J Cancer
; 126: 116-124, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31931269
10.
Cost-effectiveness evaluation of pre-counseling telephone interviews before face-to-face genetic counseling in cancer genetics.
Fam Cancer
; 17(3): 451-457, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29080081
11.
BRCA1 allele-specific expression in genetic predisposed breast/ovarian cancer.
Fam Cancer
; 16(2): 167-171, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27783335
12.
Constitutional variants are not associated with HER2-positive breast cancer: results from the SIGNAL/PHARE clinical cohort.
NPJ Breast Cancer
; 3: 4, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28649644
13.
Prognostic value of health-related quality of life for death risk stratification in patients with unresectable glioblastoma.
Cancer Med
; 5(8): 1753-64, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27252150
14.
Kinetics, prognostic and predictive values of ESR1 circulating mutations in metastatic breast cancer patients progressing on aromatase inhibitor.
Oncotarget
; 7(46): 74448-74459, 2016 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27801670
15.
GWAS in the SIGNAL/PHARE clinical cohort restricts the association between the FGFR2 locus and estrogen receptor status to HER2-negative breast cancer patients.
Oncotarget
; 7(47): 77358-77364, 2016 Nov 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-27764800
16.
Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial.
Fam Cancer
; 11(1): 77-84, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22076253
Resultados
1 -
16
de 16
1
Próxima >
>>